CYRAMZA conc perf 100 mg/10ml flac
7680652060015
CH-65206
L01FG02
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6520601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ramucirumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, glycinum, natrii chloridum corresp. natrium 17.2 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml.
Articles (1)
Cyramza 100mg/10ml, concentré pour solution de perfusion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ramucirumabum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HIMDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HIMDK |
|
glycinum
|
- | Substance | HIMDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
17.2 MG | Substance | HBESI |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 421.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2016
Authorization holder
Eli Lilly (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 65206
- Drug name
- Cyramza, concentré pour solution de perfusion
- Galenic form
- KOPA
- ATC Code
- L01FG02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/10/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CYRAMZA conc perf 100 mg/10ml flac
- Description (DE)
- CYRAMZA Inf Konz 100 mg/10ml Durchstf
- Market launch
- 29/10/2015
- Narcotic (BTM)
- No